Table 3.
Early postoperative morbidity.
| Parameters | Control group (n = 25) | Dexmedetomidine group (n = 26) | P value |
|---|---|---|---|
| Major morbidity endpoints in 30 days | |||
| Myocardial infarction | 0 | 0 | |
| Atrial fibrillation | 4 (16.0) | 2 (7.7) | 0.419 |
| Delirium | 9 (36.0) | 9 (34.6) | 0.918 |
| Cerebrovascular attack | 0 | 1 (4) | > 0.999 |
| ARDS | 4 (16.0) | 0 (0.0) | 0.051 |
| GI tract ischemia or hemorrhage | 2 (8.0) | 1(3.9) | 0.610 |
| Acute kidney injury | 7 (28.0) | 4 (15.4) | 0.274 |
| Renal replacement therapy | 3 (12.0) | 0 (0.0) | 0.110 |
| Deep sternal infection | 0 | 0 | |
| Mortality | 2 (8.0) | 0 (0.0) | 0.235 |
| Ventilator support after surgery (h) | 16.00 [10.50–22.50] | 16.00 [8.35–21.38] | 0.977 |
| Prolonged ventilator support > 24 h | 6(24.0) | 4 (15.4) | 0.499 |
| Re-intubation | 1(4.0) | 1 (3.9) | > 0.999 |
| Intensive care unit stay (h) | 58 (47.0–75.0) | 54 (46.8–97.3) | 0.985 |
| Hospital stay (day) | 18 (12.0–25.0) | 15 (11–20.8) | 0.565 |
Values are shown in number of patients (percentage), mean ± standard deviation or median (interquartile range). ARDS acute respiratory distress syndrome, GI gastrointestinal.